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Abstract
Although mice are commonly used to study different aspects of fatty liver disease, cur-
rently there are no validated fully automated methods to assess steatosis in mice. Accu-
rate detection of macro- and microsteatosis in murine models of fatty liver disease is
important in studying disease pathogenesis and detecting potential hepatotoxic signature
during drug development. Further, precise quantification of macrosteatosis is essential for
quantifying effects of therapies. Here, we develop and validate the performance of auto-
mated classifiers built using image processing and machine learning methods for detec-
tion of macro- and microsteatosis in murine fatty liver disease and study the correlation of
automated quantification of macrosteatosis with expert pathologist’s semi-quantitative
grades. The analysis is performed on digital images of 27 Hematoxylin & Eosin stained
murine liver biopsy samples. An expert liver pathologist scored the amount of macrostea-
tosis and also annotated macro- and microsteatosis lesions on the biopsy images using a
web-application. Using these annotations, supervised machine learning and image pro-
cessing techniques, we created classifiers to detect macro- and microsteatosis. For ma-
crosteatosis prediction, the model’s precision, sensitivity and area under the receiver
operator characteristic (AUROC) were 94.2%, 95%, 99.1% respectively. When correlated
with pathologist’s semi-quantitative grade of steatosis, the model fits with a coefficient of
determination value of 0.905. For microsteatosis prediction, the model has precision, sen-
sitivity and AUROC of 79.2%, 77%, 78.1% respectively. Validation by the expert patholo-
gist of classifier’s predictions made on unseen images of biopsy samples showed 100%
and 63% accuracy for macro- and microsteatosis, respectively. This novel work demon-
strates that fully automated assessment of steatosis is feasible in murine liver biopsies
images. Our classifier has excellent sensitivity and accuracy for detection of macrosteato-
sis in murine fatty liver disease.
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Introduction
Increased fat accumulation in liver cells is the hallmark of non-alcoholic fatty liver disease
(NAFLD), alcoholic fatty liver disease and hepatotoxicity from a wide range of medications
[1].
Accurate identification and quantification of steatosis are important not only for making
the diagnosis, but also for studying the pathogenesis of disease and determining the effects of
therapeutic interventions [2, 3]. It is also essential for evaluating drug hepatotoxic signature in
early drug development in animal models.
Current challenges in histological phenotyping of fatty liver, particularly in animal models,
include limited availability of experienced liver pathologists, human variability in pathologists’
agreement on detecting and quantifying various histological features of liver disease, and the
use of semi-quantitative manual grading scores that have limited range [4–9]. For example,
semi-quantitative scores for macrosteatosis or lobular inflammation have limited grading bins
(e.g., mild, moderate, severe or range from 0–3) and may not allow accurate assessment of
changes in NAFLD lesions following therapeutic interventions; smaller changes may lead the
pathologist to assignment of different grade if the changes fall on the border between grading
bins, or keep the same grade if large changes fall within same grading bin.
Automation of the assessment of fatty liver disease histological lesions provides an innova-
tive solution to these challenges [6, 10, 11]. It provides an automated, reproducible and contin-
uous measurement of these features that permits accurate measurement of wide ranges in
quantitative changes in these lesions. Using machine learning techniques, we previously devel-
oped a fully automated classifier capable of detecting and quantifying macrosteatosis in digital
images of human liver biopsies [10].
However, fully automated methods to accurately assess steatosis in murine models is lacking.
Macrosteatosis is the cardinal lesion of NAFLD, and is commonly used as a major endpoint
in therapeutic clinical trials in human NAFLD [12, 13]. Furthermore, development or improve-
ment of macrosteatosis may reflect hepatotoxic or beneficial therapeutic signature in rodent
models [14–17].
In this study, we develop automated classifiers for the identification of macro- and microstea-
tosis in murine models of fatty liver. The classifier for murine macrosteatosis is built by modifying
and introducing new features to the original classifier we developed to measure macrosteatosis in
humans [10]. We study the performance of this classifier in quantitative assessment of macrostea-
tosis in different models of murine fatty liver and evaluate the correlation of this quantification
with semi-quantitative grading given by an expert pathologist. As microsteatosis is assessed as
present or absent without further grading [4], the novel classifier for microsteatosis is built to
detect the presence or absence of microsteatosis. To assess the accuracy of the classifiers, macro-
and microsteatosis lesions identified by the classifiers on previously unseen digital images are ver-
ified by an expert pathologist.
Materials and methods
Mice liver biopsies
The dataset used for this study consisted of digital images of 27 Hematoxylin and Eosin (H&E)
stained slides of murine liver biopsies [9 with normal liver histology (no macrosteatosis: grade
0), 10 mild (macrosteatosis grade 1), 4 moderate (macrosteatosis grade 2), and 4 severe fatty
liver (macrosteatosis grade 3)]. These mice were previously used in various experimental mod-
els to induce fatty liver. Fig 1 shows representative H&E stained sub-slides of each grade type.
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All animal experimental protocols were approved by the Institutional Animal Care and Use
Committee of Indiana University (IACUC). Animals were housed under approved conditions
with 12 hour light dark cycle. C57BL/6 wild type and GFP-LC3[18] were bred in house. At 10
weeks of age, mice were placed on normal chow diet to produce normal liver, high fat diet (diet
D12492, Research diets) to produce mild fatty liver or high-fat high-carbohydrate (HFHCD)
diet, or chronic alcohol (29–36%) to produce moderate to severe fatty liver. For HFHCD diet,
mice were given high fat diet along with the drinking water enriched with high-fructose corn
syrup equivalent to a total of 42 g/L of carbohydrates. Drinking solution was made by mixing in
drinking water at a ratio of 55% fructose (Acros Organics, Morris Plains, NJ) and 45% sucrose
(Sigma- Aldrich, St. Louis, MO) by weight. Animals were provided ad libitum access to these
diets for 10–24 weeks. Only liver biopsy slides from prior concluded studies were utilized for
this study. Mice were first given Avertin (250 mg/kg, i.p.) for anesthesia, followed by cervical
dislocation for euthanization. This procedure minimizes any suffering. All procedures are
approved by the IACUC of Indiana University.
Liver biopsy H&E stained slides were studied and scored by an expert liver pathologist
(OWC) according to NASH Clinical Research Network scoring system where steatosis grade
range between 0–3 (0 < 5% steatosis, 1 = 5%-33%, 2 = 33%-66%, and 3> 66%) [4].
Biopsy slides were scanned at 20X using Aperio Scan Scope CS system. The pathologist
manually annotated the biopsy images using a custom built web-application to identify histo-
logical and anatomical features of the biopsy.
Fig 1. Representative Hematoxylin and Eosin images of different models used to induce fatty liver. A. Normal liver in wild type mouse fed chow diet. B. Mild fatty
liver in wild type mouse fed high fat diet. C. Moderate fatty liver in GFP-LC3 mouse fed alcohol. D. Severe fatty liver in GFP-LC3 mouse fed high-fat high-carbohydrate
diet.
https://doi.org/10.1371/journal.pone.0197242.g001
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Approach for macrosteatosis detection and quantification
A supervised machine learning model is trained using various regions which have a white cen-
ter: macrovesicular steatosis, microvesicular steatosis, bile duct, portal artery, portal vein, and
central vein. Fig 2 shows these regions.
Once the model identifies macrosteatosis regions among the other white regions, the per-
centage of macrosteatosis is calculated based on the area of tissue identified as fat. This value is
then correlated with the semi-quantitative grade provided by the pathologist.
The processing steps in the identification and quantification of macrosteatosis are shown in
Fig 3. More detailed explanation of each step is given below.
a) Obtaining the image: The digital image from the Aperio Scan Scope CS system is stored in
Aperio svs format. The resolution picked from svs format file is the 50% reduced one.
b) Identifying the tissue region: A region growing algorithm is applied on the green channel
of the 50% reduced RGB image to separate the tissue and background regions.
c) Identifying the white regions: The intensity image obtained from green channel is filtered
using a 3x3 averaging mask in order to smooth out noise. The intensity values in the image
are then adjusted with a GAMMA correction value of 6 to make the image darker. k-means
clustering is applied to the darkened image with a k value of 2 (i.e., 2-clusters are identified).
Pixels in the image are now divided into two classes, white and black. Any white region big-
ger than 60 pixels is eliminated and the remaining white regions are used as starting points
for further analysis.
d) Obtaining feature vector for each white region: For each of the white regions obtained
using the previous step, image features are computed to be used in learning the model. The
details of the types of attributes extracted are further explained below in the Section on Fea-
ture vector representation.
Fig 2. White regions in mouse liver biopsy.
https://doi.org/10.1371/journal.pone.0197242.g002
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e) Annotations: The computed feature vectors of regions annotated by the pathologist are
used as training patterns for learning the model. There are two types of annotations pro-
vided by the pathologist: points and polygonal regions. For point annotations, the individ-
ual white region on which the point is marked is considered. For polygonal annotations all
the white regions falling within the given polygonal boundary annotation are considered
and processed. Fig 4 shows a graphic with white and dark regions, point and polygon anno-
tations. The white regions within a polygon pointed to by arrows in the figure are used for
feature extraction for the label represented by the polygon. Similarly, the white region
pointed to by point annotation is used for extracting attributes for the given label.
f) Learning the model: Support vector machine (SVM) with a linear kernel is the machine
learning technique used for learning the model for macrosteatosis identification from the
expert pathologist’s annotations of several regions.
g) Macrosteatosis Identification: Once the trained classifier model is ready, new (i.e., previ-
ously unseen) images are processed using the trained classifier: feature vectors are com-
puted for all white regions and are used to classify each of the white regions, resulting in the
identification of macrosteatosis.
Approach for microsteatosis identification
As shown in Fig 2, microsteatosis could display different histological appearances on H&E
stained liver biopsies, from very tiny cytoplasmic vesicles, to small cytoplasmic vesicles that do
not displace the hepatocyte nucleus, to foamy appearance of the cytoplasm. A supervised
machine learning model is trained using various regions: microvesicular fat, macrovesicular
fat, lobular inflammation, portal inflammation, bile duct, portal artery, portal vein, central
Fig 3. Overall flow diagram of the approach to automated macrosteatosis identification and quantification.
https://doi.org/10.1371/journal.pone.0197242.g003
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vein and sinusoid. This trained model is then used to identify the microsteatosis regions in the
image among the other identified regions.
The processing steps in the identification of microsteatosis are shown in Fig 5. More
detailed explanation of each step is given below.
a) Obtaining the image: The digital image from the Aperio Scan Scope CS system is stored in
Aperio svs format. The resolution picked from svs format file is the 50% reduced one.
b) Identifying the tissue region: A region growing algorithm is applied on the green channel
of the 50% reduced RGB image to separate the tissue and background regions.
Fig 4. Graphic showing dark and white regions with point and polygon annotations. The white region labeled using point annotation
(represented using ’X’) is used for extracting attributes. A polygon annotation is shown using black polygon. The white regions falling within
the polygon are indicated by arrows and these are the regions used for attribute extraction for the given label.
https://doi.org/10.1371/journal.pone.0197242.g004
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c) Obtaining feature vector for region (pixel wise): For each of the images generated after
isolating the tissue area as described in step (b), Gabor filter based texture features are com-
puted. The details of the feature extraction are further explained below in the Section on
Feature vector representation.
d) Annotations: The computed feature vectors of regions annotated by the pathologist are
used as training patterns for learning the model. In the web-based annotation tool, the
microsteatosis regions are denoted by the pathologist by drawing a polygon around the
regions. The pixels falling within these annotated polygons are labeled as microsteatosis and
the computed features for these pixels are used for training the model. Because the number
of such pixels is too large, in order to reduce the computation time for the training phase,
we randomly subsampled 0.02% of the pixels annotated as microsteatosis and 0.001% of the
pixels annotated as any other histological feature.
e) Learning the model: SVM with a linear kernel is the machine learning technique used for
learning the model for microsteatosis identification from the expert pathologist’s annota-
tions of several regions.
f) Microsteatosis identification: Once the trained classifier model is ready, new (i.e., previ-
ously unseen) images are processed using the trained classifier: feature vectors based on
Gabor texture features are computed for all regions which are then used to classify them as
microsteatosis or non-microsteatosis regions.
Feature vector representation
In our prior study [10], we used image texture statistics at various scales (σ = 0,1,2,4,8) as fea-
ture vectors to be used as input to the classifier. In this study, we have extended this feature set
Fig 5. Overall flow diagram of the approach to automated microsteatosis identification.
https://doi.org/10.1371/journal.pone.0197242.g005
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to improve the accuracy of identification. We added a new set of textural features using Gabor
filters [19, 20] in detected white regions or in annotated macrosteatosis regions. For each of
the white regions, the surrounding area of 20 pixels in all directions is considered for extract-
ing these attributes. Also, a rectangular region of 25 pixels around the white region is consid-
ered for feature extraction.
Gabor filters, which are band pass filters at various frequencies and orientations, are used in
this study for texture analysis. The impulse response of a Gabor filter is the product of a sinu-
soidal plane wave at a given frequency (f = 1/λ) and orientation (θ) with a Gaussian function at
a given scale (σ).
The equation of Gabor function in spatial domain is given below [21–24]:









where Xʹ = x cos θ + y sin θ and yʹ = –x sin θ + y cos θ, are the rotated coordinates to account for
the filter orientation, λ = 1/f is the period of the sine wave, θ is the orientation of the Gabor filter,
σ is the width of the Gaussian envelope, ψ is the phase offset of the sine wave, and i =
p
-1.
Thus, the function g(x,y;λ,θ,ψ,σ) defines the convolution kernel. Filtering is performed in the
frequency domain using fast Fourier transforms as it is computationally faster.
In the macrosteatosis identification, we have used four orientations (θ = 0˚, 45˚, 90˚, and
135˚) for the Gabor filters and for each orientation five radial frequencies which are one octave
apart, for a total of 20 Gabor filters (4 orientations x 5 frequencies) [25]. These filters are
applied to 7 images (3 for RGB channels separately, 3 for HSV channels separately and one for
the gray level image) resulting in a total of 140 Gabor filter features.
These, combined with the features from our prior study [10], results in a total of 554 fea-
tures which have been used in training the classifier.
In the microsteatosis identification, we have used four orientations (θ = 0˚, 45˚, and 135˚)
for the Gabor Filters and for each orientation ten radial frequencies which are one octave
apart, for a total of 40 Gabor filters (4 orientation × 10 frequencies) [25]. These filters are
applied to a single image (gray scale), resulting in 40 Gabor filter features.
Macrosteatosis quantification
After macrosteatosis regions are identified by the trained classifier, the percent area of macrosteato-
sis in a biopsy image was quantified. Pathologists provide semi-quantitative macrosteatosis grade
based on their perception of percentage macrosteatosis area. And hence, in this study, the ratio of
measured macrosteatosis area to the total tissue area is calculated so that it can be compared with
pathologist’s grades. For each of the white regions, the area is already calculated as part of comput-
ing the morphological features. The sum of areas of all white regions identified by the classifier is
the “macrosteatosis area”. The tissue area is computed by using the background mask extracted in
the white region identification process. The image area in the regions where mask is not present is
considered as tissue and the space occupied by this region in pixels is the “tissue area.”
External validation of classifier’s accuracy
To verify the accuracy of the classifiers identifications of lesions as macro- or microsteatosis,
liver biopsy images previously unseen by the classifiers that have not been used in the training
of the classifier were used in this step. For macrosteatosis validation, fifty randomly identified
macrosteatosis lesions were selected and classified using the automated algorithm. These clas-
sification results were examined by the study pathologist to determine the validity of the
identification.
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For microsteatosis validation, one hundred and ten random sub slides from a pool of eleven
previously unseen slides were examined by the study pathologist to determine the validity of
the identification. We used a larger number of microsteatosis identified lesions for validation
in order to properly represent the slides based on the significantly smaller size of these lesions
compared to macrosteatosis lesions. The study pathologist assessed each identified (microstea-
tosis or not microsteatosis) lesion by the classifier as correct or incorrect. Accuracy was calcu-
lated as percent correctly identified with macro- or microsteatosis by the classifier as
determined by the gold standard, the study expert pathologist.
Results
Training datasets for the classifiers
The training data for learning the macrosteatosis model was the white regions annotated by
the expert, including 2256 macrosteatosis annotations from 11 liver biopsy images. The train-
ing data for learning the microsteatosis model was polygonal regions annotated as microstea-
tosis by the expert, including 570 microsteatosis annotations from 5 liver biopsy images.
Classifiers’ performance metrics
Evaluation of accuracy of macro- and microsteatosis identification was performed using a
10-fold cross validation in the training set. For macrosteatosis prediction, the model’s preci-
sion, recall (sensitivity) and area under the receiver operator characteristic (AUROC) were
94.2%, 95%, 99.1%, respectively. The classifier’s accuracy was 84.2%.
When correlated with pathologist’s semi-quantitative grade of macrosteatosis, the model
fits with a coefficient of determination R2value of 0.905. Fig 6 shows the 2nd order polynomial
curve fitted to the data points. The strong correlation between quantitative results obtained by
the algorithm developed in this study for estimating the percentage macrosteatosis and the
pathologist macrosteatosis grades are shown in Fig 7 (p = 0.01 after performing two-sample t-
test with a degree of freedom of 26). Table 1 shows the confusion matrix of the model built for
macrosteatosis prediction.
For microsteatosis prediction, the model’s precision, recall and AUROC were 79.2%, 77%,
78.1%, respectively. The classifier’s accuracy was 78.7%. Table 2 shows the confusion matrix of
the model built for microsteatosis prediction.
Fig 8 presents a visual summary of the performance metrics for the different steatosis iden-
tification models developed using supervised machine learning methods described above.
External validation of the classifiers’ accuracy
The expert pathologist validated classification results on unseen slides for detection of steato-
sis. For macrosteatosis, evaluation by the study expert pathologist of the accuracy of predic-
tions made on biopsy samples images unseen previously by the classifier, showed 100%
accuracy. For microsteatosis, of the one hundred and ten random sub slides the detection
accuracy was 63%. The pathologist also confirmed that for every unseen slide, the classifier
had accurately detected microsteatosis on at least one sub slide (i.e., 100% sensitivity for detect-
ing any microsteatosis). It is practically impossible for the pathologist to label the massive
number of macro- or microsteatosis lesions present on an individual slide, but the classifier
can do that automatically. Here we show examples in Fig 9 (for macrosteatosis) and Fig 10 (for
microsteatosis), where both the pathologist’s and classifier’s labels fell on the same lesion in the
hepatocytes but the classifier correctly labeled many other lesions in the same area of the
biopsy. Fig 11 shows an example of misclassified microsteatosis.
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Other histological features of fatty liver such as lobular inflammation or ballooning, or arti-
facts on the slides did not affect the performance of the model for detection of macrosteatosis,
as evidenced by the 100% accuracy of the classifier. However, they did for microsteatosis,
where ballooning or artifact was confused by the classifier as microsteatosis in some mislabeled
cases by the classifier (Fig 11).
Discussion
Despite intense interest in automating the assessment of steatosis in humans and animal mod-
els, there is lack of robust fully automated methods to detect and quantify steatosis in mice.
This study demonstrates that fully automated assessment of steatosis is feasible in murine liver
biopsy images. Our classifier has excellent precision, sensitivity and accuracy for detection and
quantification of macrosteatosis in mice with fatty liver disease regardless of the model used to
induce fatty liver. We also developed a novel model for identification of microsteatosis that has
good precision and high sensitivity in murine models of fatty liver.
We used a systematic approach to build and validate our models. Two sets of liver biopsies
images were used. The first set, for building, training and internally validating the models. The
second set of unseen liver images was used to externally validate the performance of the classi-
fiers. Supervised machine learning approaches were used to remedy the problem of inter- and
Fig 6. A scatter plot showing correlation between model-computed percentage steatosis for mouse biopsies with respect to the corresponding pathologist grade.
https://doi.org/10.1371/journal.pone.0197242.g006
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intra-observer error in semi-quantitative assessment of liver histological lesions. We used
biopsy samples which are in different severity of macrosteatosis as well as controls with no
macro- or microsteatosis.
There are several prior efforts, including from our group, to automate macrosteatosis
assessment in humans [10, 26]. However, robust validated methods for automated assessment
of steatosis in animal models of fatty liver are lacking. Others have also attempted quantifying
macrosteatosis using machine learning and digital image analysis in rats and mice [27–29]. In
one study for example, automated detection of fat droplets in rats showed more than 90%
specificity and sensitivity [28], but the study lacked external validation of the identified steato-
sis lesions. In rats fed methionine-choline-deficient plus high-fat diet, the same group noted
no correlation between their automated method of quantifying steatosis versus pathologist’s
visual estimate for mild and moderate degrees of steatosis. Our method for quantifying
Table 1. The confusion matrix and metrics for the model built to detect macrosteatosis.
Actual Predicted
Central Vein Macro Fat Bile Duct Portal Vein Portal Artery PRECISION (%)
Central Vein 230 8 0 25 0 87.45
Macro Fat 6 343 0 12 0 95.01
Bile Duct 0 1 17 27 5 30.91
Portal Vein 15 8 14 298 2 87.9
Portal Artery 2 4 4 7 13 37.14
RECALL (%) 90.91 94.23 41.46 79.25 52
https://doi.org/10.1371/journal.pone.0197242.t001
Fig 7. Mixed line/bar chart showing the correlation between the computed percentage steatosis with the expert pathologist grade. The pathologist grade for
mouse samples is shown as a bar matching the left axis, and the computed percentage steatosis is shown as a line matching the right axis.
https://doi.org/10.1371/journal.pone.0197242.g007
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macrosteatosis has excellent correlation with pathologist’s semi-quantitative assessment with a
R2 value of 0.905. The severity of macrosteatosis and its zonal distribution did not affect the
classifier’s performance, which remained accurate across all severities of fatty liver slides
included in the training and validation phases of the study and regardless of the zonality of
macrosteatosis. All lesions detected by the classifiers on unseen images were validated as true
by the study pathologist.
It should be noted that our study had no bias when biopsy samples were selected. Therefore,
our algorithm is robust to variations in the intensity if H&E stain on the sample and to the
noise introduced during the image acquisition and/or slide preparation process.
Macrosteatosis is the cardinal lesion of NAFLD and a key feature of alcoholic liver disease
and drug hepatotoxicity [30, 31]. Therefore, accurate detection and quantification of this lesion
is essential to studying these disease processes. While imaging modalities such as ultrasound,
computed tomography, and magnetic resonance imaging, have been routinely used in clinical
Table 2. The confusion matrix and metrics for the model built to detect microsteatosis.
Actual Predicted
Micro Fat Others PRECISION (%)
Micro Fat 7109 1862 79.24
Others 2116 7660 78.35
RECALL (%) 77.06 80.445
https://doi.org/10.1371/journal.pone.0197242.t002
Fig 8. A graph which represents the different models generated and their respective metrics.
https://doi.org/10.1371/journal.pone.0197242.g008
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care of humans with fatty liver disease as non-invasive tools to assess hepatic steatosis, these
methods are not suited for assessment of steatosis in murine models of fatty liver, where liver
biopsy remains a viable and routinely used tool to study the pathogenesis of the disease or
measure the effects of new therapeutic agents in preclinical animal studies. Current assessment
of steatosis in liver biopsy relies on the availability and access to highly skilled pathologists
who perform a manual evaluation of liver biopsy slides and generate a semi-quantitative score
for macrosteatosis. This assessment is subject to human variability. Our fully automated
method allows accurate, reproducible and continuous measurement of macrosteatosis. Fur-
ther, the H&E stain is the most widely used in clinical and research practices to evaluate
macrosteatosis. We therefore developed this method using only the H&E stains so that no
additional special stains will be needed to make this measurement.
Microsteatosis is uncommonly seen in the setting of human non-alcoholic fatty liver dis-
ease, but when present may indicate increased disease severity [32]. It is also seen in the setting
of drug induced hepatotoxicity [31]. It is therefore an important hepatic lesion to identify espe-
cially during drug development in animal models [14, 33]. To our knowledge, no prior
Fig 9. Comparison of annotated macrosteatosis lesions by pathologist v/s our model. The left slide contains
annotations given by the pathologist (marked as a point in magenta). The right slide contains macro fat lesions
detected by the model (marked as point in dark blue).
https://doi.org/10.1371/journal.pone.0197242.g009
Fig 10. Comparison of annotated microsteatosis lesions by pathologist v/s our model. The left slide contains
annotations given by the pathologist (marked as polygons in dark blue). The right slide contains micro fat lesions
detected by the model (marked as polygons in green).
https://doi.org/10.1371/journal.pone.0197242.g010
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attempts have been undertaken to automate the identification of microsteatosis in liver biopsy
images. Although our results show promising performance of this novel classifier to detect
microsteatosis, there is room for further improvement of the classifier’s accuracy for detection
of this challenging lesion. Some of the classifier’s labels were deemed incorrect by the patholo-
gist due to different reasons, such as the classifier confusing artifact on the slide as microsteato-
sis (Fig 11), or incorrectly labeling ballooning of the hepatocytes as microsteatosis. We believe
these problems with microsteatosis detection can be improved by adding far more annotations
by the pathologist of microsteatosis to train the model and by creating different types of fea-
tures (orientation based).
In summary, we have developed and validated a fully automated and highly accurate classi-
fier to detect and quantify macrosteatosis and also a novel model to detect microsteatosis in
murine fatty liver. The ability to accurately assess macro- and microsteatosis on the H&E
stained slides without additional sophisticated stains is one strength of this work. This classifier
could be a valuable tool in assessing murine fatty liver disease in various experimental and
therapeutic conditions.
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